Overtech Corp.
OTCBB : OVET

November 20, 2014 14:50 ET

Overtech Files 8-K and Name Change in Accordance With Acquisition of Beatmungspflege 24 GmbH

STUTTGART, GERMANY--(Marketwired - Nov. 20, 2014) - Overtech Corp. (OVET) Overtech Corp. (the "Company" or "Overtech") (OTCBB:OVET) is pleased to announce that it has completed the filing on November 19, 2014 of its Current Report on Form 8-K (the "Super 8-K") disclosing the closing of the acquisition of Beatmungspflege 24 GmbH (the "GmbH"). As a result of completion of the acquisition and filing of the Super 8-K, the company is no longer considered a shell company under SEC rules.

As a post-closing matter, the directors of Overtech and its subsidiary, Medicus Homecare Inc., have agreed to merge effective December 12, 2014. As a result of the merger, Overtech's name will become Medicus Homecare Inc. The Company is seeking the granting of a new trading symbol that is more appropriate to its new name and business in connection with the regulatory approval of the merger and name change.

Completion of the merger and name change is subject to all regulatory filings and approvals.

Forward-Looking Statements

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Overtech cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond their control. Such factors include, among other things: risks and uncertainties relating to their business plan, their ability to raise sufficient financing and their limited operating history. In particular, there is no assurance that the Company's filings and the regulatory approvals will be completed by the anticipated merger date. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, Overtech undertakes no obligation to publicly update or revise forward-looking information. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that Overtech Corp. files from time to time with the SEC, including its Annual, Quarterly and Current Reports.

Contact Information